While healthy controls universally mounted robust IgG and IgA responses, patients with NHL/CLL exhibited a variable response, with a significant proportion mounting no discernible responses after booster vaccination (Fig. 1). This evidence concerns the gene CD79A and non-Hodgkin lymphoma.